The dominant part of clinical trials conducted by BioStat® is research on the introduction of new drugs to the market. We help pharmaceutical and biotechnology clients in the process of searching for new, more effective drugs, but also in the evaluation of existing drugs, the therapeutic value of which is not fully known.
A medicinal product commonly known as a drug, is a substance or mixture of substances with the properties of preventing or treating specific disease entities.
Before a drug becomes widely used, it must go through a process of preclinical and clinical trials. In Poland, a marketing authorization is issued by the Office for Registration of Medicinal Products, Medical Devices and Biocidal Products.
There are two types of medicinal products: an innovative drug (also known as the reference drug) and a generic drug, which is a replacement for an innovative product.
We conduct single- and multi-center research in Poland and abroad. Therapeutic areas in which we have so far conducted clinical trials for medicinal products include:
During the research, we mainly work in the model Sponsor - CRO - BioStat®, being responsible for:
Frequently asked questions.
